Khaitan & Co acts on demerger of India Glycols businesses

The demerger has been approved by the stock exchanges and SEBI and is pending approval of the NCLT and shareholders and unsecured creditors.

Bar & Bench

Published:2nd Feb, 2026 at 11:30 AM

India Glycols Limited is executing a demerger of its bio pharma undertaking and spirits & biofuel undertaking into two separate listed companies, namely, Ennature Bio Pharma Limited and IGL Spirits Limited.

Khaitan & Co is advising India Glycols on this demerger.

The transaction team consisted of Atul Pandey (Partner), Hirak Mukhopadhyay (Partner) and Varun Yadav (Principal Associate).

Atul Pandey, Hirak Mukhopadhyay

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Follow Bar and Bench channel on WhatsApp

Download the Bar and Bench Mobile app for instant access to the latest legal news.

Khaitan & Co acts on demerger of India Glycols businesses

The demerger has been approved by the stock exchanges and SEBI and is pending approval of the NCLT and shareholders and unsecured creditors.

Also Read

IC RegFin Legal, Goyel & Goyal act on Raana Semiconductors seed fundraise

Can CCI examine competition issues arising from patent disputes? Supreme Court to decide

Soni Tiwari made Partner at Mori Hamada & Matsumoto

Telangana High Court asks trial court to decide Digi Yatra IP injunction plea in four weeks

Budget 2026–27: Cautiously optimistic